Phase II Open-label Trial of Neoadjuvant Immunochemotherapy for Resectable Non-metastatic Colon cancER: NICER

Clinical trial NCT05870800 · RECRUITING

Trial details

NCT number: NCT05870800
Sponsor: Baylor College of Medicine
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Stage I Colon Cancer Stage II Colon Cancer Stage III Colon Cancer

Start date: 2025-06-15
Primary completion: 2026-09-01
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.